Curated patient and professional education across public, reserved, and portal-adjacent reading paths.
Public
Explains the cancers HPV can cause, current U.S. and global burden, historical trends, survival statistics as population context, and the access and stigma barriers that shape outcomes.
Public
A detailed patient guide to oral HPV and HPV-related oropharyngeal cancer: what HPV is, why most infections do not become cancer, why there is no routine throat HPV screening test, what symptoms need review, and why blame does not help.
Public
A warm introduction to HPV: what the virus is, how common it is, how low-risk and high-risk types differ, why persistence matters, and why a diagnosis does not prove fault or infidelity.
Public
Explains how to reduce HPV-related harm through vaccination, screening, barrier protection, symptom awareness, treatment, follow-up, tobacco reduction, and inclusive public education.
Public
A detailed explanation of HPV types, what low-risk and high-risk mean, why exposure is hard to recognise, which symptoms deserve review, and what HPV tests can and cannot show.
Restricted
HPV-positive oropharyngeal cancer often responds well to treatment, but treatment can be difficult. This reserved article explains why researchers study de-intensification, why it is not a shortcut, and why decisions must stay with specialist teams.
Public
Finishing treatment is a milestone, but it is not the end of care. This article explains what follow-up is for, why recovery can feel slow, and how people can ask for help with swallowing, speech, dental health, fatigue and anxiety.
Restricted
Blood antibodies against HPV16 can tell researchers something important about risk and tumour biology, but they are not a simple screening answer for the public. This reserved article explains why.
Public
HPV vaccination is one of the strongest cancer-prevention tools we have, but it is often explained too narrowly. This article connects vaccination with oral HPV, throat cancer risk, European and WHO prevention goals, and the careful limits of what current evidence can promise.
Restricted
Modern HPV detection can sound simple, but it is not. This reserved article explains p16, HPV DNA and RNA testing, liquid biopsy and biomarker research, while making clear that these tools do not yet create a routine oral HPV screening programme.
No articles match the current filters.
Reads selected text first, otherwise the current article or main page content.
